Emerging Prognostic Groups Across the Spectrum of Metastatic Castration-Sensitive Prostate Cancer: Disease Outcomes and Genomics

被引：0

作者：

Sutera, P. ^{[1
]}

Van der Eecken, K. ^{[2
]}

Kishan, A. U. ^{[3
]}

Hamid, A. ^{[4
]}

Grist, E. ^{[5
]}

Attard, G. ^{[6
]}

Lotan, T. L. ^{[7
]}

Mendes, A. ^{[1
]}

Sweeney, C. ^{[8
]}

Paller, C. ^{[9
]}

Carducci, M. ^{[9
]}

Ross, A. E. ^{[10
]}

Pienta, K. ^{[11
]}

Feng, F. Y. ^{[12
]}

Eisenberger, M. ^{[9
]}

Antonarakis, E. S. ^{[9
]}

Ost, P. ^{[13
]}

Tran, P. T. ^{[11
]}

Deek, M. P. ^{[9
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[2] Univ Ghent, Ghent, Belgium

[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Inst Canc Res Royal Marsden, London, England

[6] Inst Canc Res, London, England

[7] Johns Hopkins Sch Med, Dept Pathol & Oncol, Baltimore, MD USA

[8] Dana Farber Inst, Boston, MA USA

[9] Johns Hopkins Med, Baltimore, MD USA

[10] Northwestern Univ, Chicago, IL 60611 USA

[11] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA

[12] Univ Calif San Francisco, San Francisco, CA 94143 USA

[13] Ghent Univ Hosp, Dept Radiat Oncol, Ghent, Belgium

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2596

引用

页码：E294 / E295

页数：2

共 50 条

[1] Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics
Sutera, Philip
Van der Eecken, Kim
Kishan, Amar U.
Hamid, Anis
Grist, Emily
Attard, Gerhardt
Lotan, Tamara
Mendes, Adrianna A.
Paller, Channing J.
Carducci, Michael A.
Ross, Ashley
Wang, Hao
Pienta, Ken
Feng, Felix Y.
Antonarakis, Emmanuel S.
Ost, Piet
Song, Daniel Y.
Greco, Stephen
Deville, Curtiland
DeWeese, Theodore
Tran, Phuoc T.
Deek, Matthew P.
PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (04) : 713 - 719
[2] Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics
Philip Sutera
Kim Van Der Eecken
Amar U. Kishan
Anis Hamid
Emily Grist
Gerhardt Attard
Tamara Lotan
Adrianna A. Mendes
Channing J. Paller
Michael A. Carducci
Ashley Ross
Hao Wang
Ken Pienta
Felix Y. Feng
Emmanuel S. Antonarakis
Piet Ost
Daniel Y. Song
Stephen Greco
Curtiland Deville
Theodore DeWeese
Phuoc T. Tran
Matthew P. Deek
Prostate Cancer and Prostatic Diseases, 2022, 25 : 713 - 719
[3] Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer
MacVicar, Gary R.
Hussain, Maha H.
CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 252 - 260
[4] Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
Miyake, Hideaki
Matsushita, Yuto
Watanabe, Hiromitsu
Tamura, Keita
Motoyama, Daisuke
Ito, Toshiki
Sugiyama, Takayuki
Otsuka, Atsushi
ANTICANCER RESEARCH, 2019, 39 (03) : 1391 - 1396
[5] Chemotherapy for metastatic castration-sensitive prostate cancer
Parimi, Sunil
Chi, Kim N.
INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (09) : 726 - 733
[6] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
Chi, Kim N.
Agarwal, Neeraj
Bjartell, Anders
Chung, Byung Ha
Pereira de Santana Gomes, Andrea J.
Given, Robert
Juarez Soto, Alvaro
Merseburger, Axel S.
Ozguroglu, Mustafa
Uemura, Hirotsugu
Ye, Dingwei
Deprince, Kris
Naini, Vahid
Li, Jinhui
Cheng, Shinta
Yu, Margaret K.
Zhang, Ke
Larsen, Julie S.
McCarthy, Sharon
Chowdhury, Simon
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 13 - 24
[7] The cost impact of disease progression to metastatic castration-sensitive prostate cancer
Quoc-Dien Trinh
Chaves, Leonardo Passos
Feng, Qi
Zhu, Julia
Sandin, Rickard
Abbott, Thomas
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (05): : 544 - 554
[8] The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Deek, Matthew P.
Van der Eecken, Kim
Phillips, Ryan
Parikh, Neil R.
Velho, Pedro Isaacsson
Lotan, Tamara L.
Kishan, Amar U.
Maurer, Tobias
Boutros, Paul C.
Hovens, Christopher
Abramowtiz, Matthew
Pollack, Alan
Desai, Neil
Stish, Bradley
Feng, Felix Y.
Eisenberger, Mario
Carducci, Michael
Pienta, Kenneth J.
Markowski, Mark
Paller, Channing J.
Antonarakis, Emmanuel S.
Berlin, Alejandro
Ost, Piet
Tran, Phuoc T.
EUROPEAN UROLOGY, 2021, 80 (05) : 632 - 640
[9] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
Sheridan M. Hoy
Drugs, 2020, 80 : 1579 - 1585
[10] Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or ...
Barata, Pedro C.
Sartor, A. Oliver
CANCER, 2019, 125 (11) : 1777 - 1788

← 1 2 3 4 5 →